본문 바로가기
KERD
논문KCI 등재

Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발

Development of Human Antibody Inhibiting RNase H Activity of Polymerase of Hepatitis B Virus Using Phage Display Technique

0

조회

0

다운로드

0

인용

0

참고문헌

초록

Abstract

Background: To develop a novel treatment strategy for hepatitis B virus infection, a major cause of liver chirosis and cancer, we aimed to make human monoclonal antibodies inhibiting RNase H activity of P protein playing in important role in HBV replication. In this regard, phage display technology was employed and demonstrated as an efficient cloning method for human monoclonal antibody. So this study analysed the usability of human monoclonal antibody as protein based gene therapy. Methods: RNase H of HBV was expressed as fusion protein with maltose binding protein and purified with amylose resin column. Single chain Fv (scFv) phage antibody library was constructed by PCR cloning using total RNAs of PBMC from 50 healthy volunteers. Binders to RNase H were selected with BIAcore 2000 from the constructed library, and purified as soluble antibody fragment. The affinity and sequences of selected antibody fragments were analyzed with BIAcore and ABI automatic sequencer, respectively. And finally RNase H activity inhibiting assay was carried out. Results: Recombinant RNase H expressed in E. coli exhibited an proper enzyme activity. Naive library of 4.46×109 cfu was screened by BIAcore 2000. Two clones, RN41 and RN56, showed affinity of 4.5×10-7 M and 1.9×10-7 M, respectively. But RNase H inhibiting activity of RN41 was higher than that of RN56. Conclusion: We cloned human monoclonal antibodies inhibiting RNase H activity of P protein of HBV. These antibodies can be expected to be a good candidate for protein-based antiviral therapy by preventing a replication of HBV if they can be expressed intracellularly in HBV-infected hepatocytes. (Immune Network 2004;4(1):16-22)

참고문헌 (28)

  1. "Molecular virology and pathogenesis of hepatitis B. Lancet 342", pp.1335~1340 (1993)
  2. "Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119", pp.312~323 (1993)
  3. "controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 323", pp.295~301 (1990)
  4. "The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis", pp.646~655 (1994), Krogsgaard K
  5. "Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers", 25, pp.241~244 (1997)
  6. "Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.", 4, pp.20~22 (1997)
  7. "Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.", 24, pp.714~717 (1996)
  8. "Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 337" (1991)
  9. "In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 12", pp.1257~1262 (1993)
  10. "hepatitis B virus as a clinical example. Lancet 341", pp.349~353 (1993)
  11. "Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants", 26, pp.251~255 (1997)
  12. "Single-chain antigen-binding proteins.", 242, pp.423~426 (1998)
  13. "Schaller H. Mutational analysis of the hepatitis B virus P gene product", pp.613~620 (1990)
  14. "Phage display, a laboratory manual" (2001), CSHL press
  15. "Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 84", pp.444~448 (1987)
  16. "The catalytic properties of human hepatitis B virus polymerase.", 223, pp.264~271 (1996)
  17. "Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin", pp.4513~4520 (1993)
  18. "Production of human IgM warm reacting red cell monoclonal autoantibodies by Epstein- Barr virus transformation. Transfusion 101"
  19. "Antigen-specific human antibodies from mice comprising four distinct modifications. Nature 368", pp.856~859 (1994)
  20. "Making antibodies by phage display technology. Ann Rev Immunol 12", pp.433~455 (1994)
  21. "By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222", pp.581~597 (1991)
  22. "Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13", pp.3245~3260 (1994)
  23. "Selection of binders from phage displayed antibody libraries using the BIAcore biosensor.", 198, pp.51~57 (1996)
  24. "Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol 226", pp.889~896 (1992)
  25. "Use of living columns to select specific phage antibodies. Biotechnology", pp.1565~1569 (1993)
  26. "Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells selection of specific antibodies from single-chain Fv fusion phage libraries.", 92, pp.6537~6541 (1995)
  27. "Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments.", 94, pp.3903~3908 (1997)
  28. "Phage antibodies: filamentous phage displaying antibody variable domains."

관련 논문AI추천

이 간행물의 다른 논문 (8건)